Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Business Times.
Press releases published on April 25, 2025
Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
GlobeNewswire
·
April 25, 2025
CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced today the presentation of a poster featuring new findings …
Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit
GlobeNewswire
·
April 25, 2025
Hong Kong, April 25, 2025 (GLOBE NEWSWIRE) -- On April 22, 2025, the "Towards the Light: Co-creating a New Global Journey in the AI Field — 2025 AI Intelligent Development Summit" grandly opened at the Hop Hing Hotel in Hong Kong, China. This forum focused …
SAG HOLDINGS LIMITED CHANGE ITS NAME TO INNEOVA HOLDINGS LIMITED
GlobeNewswire
·
April 25, 2025
Corporate Rebranding Marks New Era of Engineering Excellence and Sustainable Solutions SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- SAG Holdings Limited today announced that it has changed its name to INNEOVA Holdings Limited (“INNEOVA Holdings” or the “ …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Open Lending Corp. - LPRO
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Open Lending Corp. (“Open Lending” or the “Company”) (NASDAQ: LPRO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altria Group, Inc. - MO
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Altria Group, Inc. (“Altria” or the “Company”) (NYSE: MO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581 …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Greenbrier Companies, Inc. - GBX
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Greenbrier Companies, Inc. (“Greenbrier” or the “Company”) (NYSE: GBX). Such investors are advised to contact Danielle Peyton at newaction@ …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Strategy Incorporated (f/k/a MicroStrategy Incorporated) - MSTR
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Strategy Incorporated (f/k/a MicroStrategy Incorporated) (“Strategy” or the “Company”) (NASDAQ: MSTR). Such investors are advised to contact …
American Rebel CEO Andy Ross Harnesses Media Appearance on NBC-TV West Palm Beach Affiliate to Amplify Growth Strategy, Propel Brand Expansion and Launch American Rebel Light Beer in Florida
GlobeNewswire
·
April 25, 2025
From Song to Strategy: American Rebel's CEO Andy Ross Shares the Brand's Journey with Sunshine Spotlight Host Fiona Daghir Detailing the Journey of America’s Patriotic Brand to Becoming the Next Great American Success Story. West Palm Beach, FL, April 25, …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Watsco, Inc. - WSO
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Watsco, Inc. (“Watsco” or the “Company”) (NYSE: WSO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980 …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Movado Group, Inc. - MOV
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Movado Group, Inc. (“Movado” or the “Company”) (NYSE: MOV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines – ZBIO
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@ …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of TechTarget, Inc. – TTGT
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ: TTGT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Uber Technologies, Inc. – UBER
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Uber Technologies, Inc. (“Uber” or the “Company”) (NYSE: UBER). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CarMax, Inc. - KMX
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kyndryl Holdings, Inc. - KD
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agilysys, Inc. - AGYS
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agilysys, Inc. (“Agilysys” or the “Company”) (NASDAQ: AGYS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646 …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ibotta, Inc of Class Action Lawsuit and Upcoming Deadlines - IBTA
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zenas BioPharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ZBIO
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NYSE: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@ …